- Retrospective cohort of adult cardiac surgery patients using cell salvage, analyzed as a routine coagulation cohort (N = 677) and an exploratory viscoelastic cohort (N = 50).
- Exposure was cell salvage reinfusion volume, with paired hemostatic measurements before and after and no coagulation-affecting blood products between them.
- In the routine coagulation cohort, CS volume was not significantly associated with absolute changes in any parameter (all p ≥ 0.144).
- In the viscoelastic cohort, higher CS volume was associated with lower functional fibrinogen clot strength (CFF MA β = -3.31 mm/L; 95% CI -5.53 to -1.08; adjusted p = 0.031), while the CK MA association did not survive correction.
Latest papers
Results for “transfusion cardiac restrictive OR transfusion cardiac liberal”.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This single-center, retrospective before-after study compared 229 elective cardiac surgery patients on an ERAS-PBM pathway with 162 pre-ERAS patients from 2019.
- The ERAS-PBM pathway added preoperative anemia screening and treatment, adherence to restrictive transfusion thresholds, blood conservation, and care bundles run by an ERAS nurse.
- RBC transfusion fell from 38.9% to 23.6% (p = 0.0012), and the exploratory adjusted OR for transfusion was 0.59 (95% CI 0.36-0.98; p = 0.041).
- Complications fell from 66.7% to 46.3% and hospital stay shortened from 12 to 9 days, and the authors call for larger multicenter prospective studies.
- This narrative review synthesizes fourteen original studies covering nearly 220,000 patients from over 1,000 centres worldwide.
- It focuses on platelet concentrate and fresh frozen plasma use in adult cardiac surgery and how hemostatic therapy varies between centres.
- Platelet and plasma transfusion rates differed significantly across centres, and patient and procedural characteristics do not fully explain these differences.
- Viscoelastic tests have improved assessment in some settings but have not eliminated variation, which the authors attribute partly to hospital culture, organization, thresholds and human factors.
- Protocol for a multicentre randomized controlled trial in patients aged 60 or older with anaemia (haemoglobin ≤90 g/l) undergoing surgery for hip fracture.
- Compares a liberal transfusion strategy (haemoglobin target 90 to 110 g/l) with a restrictive strategy (target 75 to 90 g/l) from randomization to discharge or 30 days.
- No efficacy results are reported; the primary outcome is a composite of death or major adverse cardiac events, adjudicated by blinded experts, with quality of life assessed at 120 days.
- The authors reduced the target sample size from 1,984 to 842 and added myocardial injury after non-cardiac surgery (MINS) to the primary outcome after recruitment fell short.
- This narrative review of red blood cell transfusion thresholds draws on 2021–2026 trials, meta-analyses, and guidelines identified through PubMed and Google Scholar searches.
- It compares restrictive (Hb 7–8 g/dL) and liberal (Hb above 10 g/dL) strategies, then considers population-specific exceptions and ultra-restrictive thresholds (Hb <6–7 g/dL).
- The 2025 Cochrane update (48 trials, >20,000 participants) reported that restrictive strategies reduced the proportion receiving at least one transfusion by 41%, without increasing 30-day mortality or major morbidity.
- Restrictive thresholds appear safe in stable critically ill patients, non-cardiac surgery, and acute GI bleeding, while acute MI, neurocritical care, thalassemia, and hematologic malignancies need individualized approaches.
- A mixed-methods quality initiative at one high-volume cardiac surgery center combined a retrospective review of 24,005 adult patients (2018–2024) with a survey of 112 of 258 providers.
- The retrospective analysis examined modifiable risk factors, including preoperative anemia, malnutrition, hypothermia, hyperglycemia, and antifibrinolytic use, and their association with transfusion.
- Transfusion occurred in 55.9% of patients; preoperative anemia (IRR 1.74, 95% CI 1.67-1.83) and hypothermia (IRR 1.66, 95% CI 1.59-1.73) were linked to higher risk-adjusted transfusion, while antifibrinolytics were linked to less (IRR 0.90, 95% CI 0.86-0.93).
- Many transfusions were given without laboratory guidance (RBC 32.1%, plasma 82.4%), and 81% of responding providers endorsed a restrictive hemoglobin threshold of under 7.5 g/dL for stable patients.
- Retrospective multicentre cohort of 25,697 adult cardiac surgery patients from two Danish tertiary centres, covering 2000 to 2024.
- Anaemia at hospital discharge was classified by WHO sex-specific criteria as mild or moderate-severe, and 93.1% of patients were anaemic.
- Moderate-severe anaemia was independently associated with worse survival (adjusted HR 1.11, 95% CI 1.01-1.21, p = 0.034), while discharge haemoglobin added little prognostic information beyond baseline factors.
- Haemoglobin plateaued about 4 months after discharge but stayed below baseline at 1 year, and the authors describe the postoperative anaemia association as weak and support further trials.
- Multicenter randomized trial at two Chinese hospitals enrolled 253 patients aged 60 or older undergoing non-cardiac surgery, randomized 1:1.
- Patients were assigned to POTTS-guided transfusion, a score built from adrenaline use, FiO2, temperature and angina history, or to control care following the 2012 AABB guideline.
- Transfusion was required in 24.00% (30/125) of POTTS patients versus 35.94% (46/128) of controls (p = 0.038), with no significant difference in transfusion volume.
- The authors concluded POTTS reduced the proportion transfused without increasing complications, though complication rates were 12.80% versus 8.59% (p = 0.279), not significantly different.
- This scoping review (PRISMA-ScR) mapped 57 primary studies and 15 reviews on 4-factor PCC in adults undergoing on-pump cardiac surgery.
- The comparator was FFP, and reported PCC dosing ranged from fixed 500-4000 IU to weight-based 15-30 IU/kg.
- Evidence consistently suggests PCC reduces chest tube output and transfusion versus FFP, though effect sizes vary; no pooled estimates are reported.
- The authors conclude that gaps remain on optimal dose, timing, viscoelastic targets, and fibrinogen sequencing, with limited cost-effectiveness data and rare serious adverse events.
- Mixed-methods study in two Baltimore ICUs (cardiac surgical and surgical), combining 52 observed patient encounters, provider surveys, and chart review.
- No intervention was tested; the authors compared prescribers with bedside nurses on their views of the ideal pretransfusion hemoglobin and on actual practice.
- Prescribers in both units (87% and 90%) more often than nurses (8% and 42%) named 7 g/dL or lower as ideal for nonbleeding patients (p = 0.002 and 0.015).
- The authors concluded that knowledge gaps, overly optimistic views of current practice, and variable thresholds between prescribers are barriers, and that targeted interventions are needed.